NARI — Inari Medical Balance Sheet
0.000.00%
- $4.68bn
- $4.57bn
- $493.63m
Annual balance sheet for Inari Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 23.6 | 164 | 176 | 326 | 115 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 11.3 | 28 | 42.4 | 58.6 | 70.1 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 39.4 | 206 | 245 | 423 | 236 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 3.33 | 7.5 | 61.4 | 72.4 | 69.3 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 44.5 | 214 | 312 | 504 | 674 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 8.87 | 13.8 | 42.5 | 56.2 | 76.3 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 29.5 | 13.8 | 72.3 | 87.2 | 209 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 15 | 200 | 239 | 417 | 465 |
Total Liabilities & Shareholders' Equity | 44.5 | 214 | 312 | 504 | 674 |
Total Common Shares Outstanding |